- AU$8.30m
- AU$24.26m
- AU$9.31m
Brief: Cann Group Signs Variation Agreement With Key Customer
Brief: Cann Group Says Julian Chick Appointed To Role Of Deputy Chair
Brief: Cann Group Posts Unaudited Year To Date Sales Revenue Of A$13.5M
Australia's Cann Group jumps on strong crop harvest in July
Brief: Cann Group Says Latest Harvest Confirms Co On Track To Achieve 12.5 Tonne Volume Target
Brief: Cann Group Says Mildura Production Increases To 2.2 Tonnes In FY23
Australia's Cann Group surges on higher revenue expectations
Brief: Cann Group Says Julian Chick Appointed As Deputy Chair
Brief: Cann Group Says Received Notification From Haleon Australia Regarding Agreement Termination
Brief: Cann Group Says Sales Revenue For Quarter Was A$4.05 Mln
Brief: Cann Group Says Sativite To Acquire Business Assets Of Cann At Southern Facility
Brief: Cann Group Posts HY Revenues From Ordinary Activities Of A$5.8 Million
Brief: Cann Group Says Unaudited Sales Revenue For Quarter Was A$3.849 Mln
Australia's Cann Group hits record low on disappointing clinical trial results
Brief: Cann Group Announces Preliminary Results From Their Phase 3 Clinical Trial
Australia's Cann Group up 2.4% on CEO change
Brief: Cann Group Appoints Peter Koetsier As New CEO
Brief: Cann Group Reaches Terms With Sativite
Australia's Cann Group rises on drug marketing deal